04 Oct, 2016 BMJ Confirms J&J and Janssen Hid Faulty Device Concerns During Xarelto Study By Andrew Steinberg | Current Litigation & Lawsuit News,Dangerous Prescription Drug | 0 Comments The controversy surrounding the anticoagulant Xarelto is reaching a fevered pitch, and the British Medical Journal (BMJ) just added more fuel to the fire. Johnson & Johnson (J&J) subsidiary... Read More
